Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. - Wikidata - awgldk - TriplyDB

Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin.

Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin.

http://www.wikidata.org/entity/Q35328384

about

Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice.HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesis.Optimized surgical techniques and postoperative care improve survival rates and permit accurate telemetric recording in exercising mice Optimal hematocrit for maximal exercise performance in acute and chronic erythropoietin-treated mice Activation of the hypoxia-inducible factor pathway induced by prolyl hydroxylase domain 2 deficiency enhances the effect of running training in mice.A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury Erythropoietin action in stress response, tissue maintenance and metabolism.Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration Erythropoietin, a novel versatile player regulating energy metabolism beyond the erythroid system Macrophages as novel target cells for erythropoietin.Nitric oxide synthase mediates the ability of darbepoetin alpha to improve the cognitive performance of STOP null mice Erythropoietin prevents endothelial dysfunction in GTP-cyclohydrolase I-deficient hph1 mice Nitric oxide in RBCs.The anaemia of silent diabetic nephropathy-prevalence, physiopathology, and management.Erythropoietin in the intensive care unit: beyond treatment of anemia.High-altitude diving in river otters: coping with combined hypoxic stresses.β Common Receptor Mediates Erythropoietin-Conferred Protection on OxLDL-Induced Lipid Accumulation and Inflammation in Macrophages.Carbamylated erythropoietin ameliorates the metabolic stress induced in vivo by severe chronic hypoxia Flow-mediated vasodilation in end-stage renal disease A novel protective effect of erythropoietin in the infarcted heart Endogenous erythropoietin signaling facilitates skeletal muscle repair and recovery following pharmacologically induced damage Role of erythropoietin in the brain Anaemia and the heart.Diabetic nephropathy and anaemia.Erythropoietin and normal brain development: receptor expression determines multi-tissue response.Erythropoietin and cerebral vascular protection: role of nitric oxide.Acute erythropoietin cardioprotection is mediated by endothelial response.Erythropoietin contributes to slow oxidative muscle fiber specification via PGC-1α and AMPK activation.The role of erythropoietin as an inhibitor of tissue ischemia.Decreased stability of erythroblastic islands in integrin β3-deficient mice.PPARα and Sirt1 mediate erythropoietin action in increasing metabolic activity and browning of white adipocytes to protect against obesity and metabolic disorders.Presence of the Gpr179(nob5) allele in a C3H-derived transgenic mouse.Cardiovascular effects of erythropoietin an update.Polycythemia is associated with bone loss and reduced osteoblast activity in mice.Nitric oxide and hypoxia stimulate erythropoietin receptor via MAPK kinase in endothelial cells Erythropoietic and non-erythropoietic functions of erythropoietin in mouse models.Red blood cell volume and the capacity for exercise at moderate to high altitude.High hematocrit resulting from administration of erythropoiesis-stimulating agents is not fully predictive of mortality or toxicities in preclinical species.Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development.Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development.

P2860

Q28590550-DE03DE85-A6DA-4225-8DB9-66FDB1DC4F6F Q33404963-40A52416-DB22-40F6-93AE-6CA480021049 Q33489091-EC729E3C-7939-4169-8F33-D9FA79D54EBD Q33591701-D33373B5-52F3-49D6-A2AC-EC8E7809D63C Q33626148-502EA772-04D5-48AB-A5D8-A30E8AE17D87 Q33836284-D52A8DAF-235F-458C-89F5-880DFFBCFA58 Q33907747-C41673B9-CD15-4D55-907E-8CE54394A315 Q34090917-0F3DD487-7300-4F53-8EE6-49BAB0C6027E Q34100489-F9897206-1C5E-4790-B4E2-35CD13C95EC1 Q34255067-2B2BE69E-33AB-40F5-8C8F-873F74879ECA Q34661087-9D7081DF-A79B-44A7-8906-0969BB594989 Q34668310-F016BAD7-D6A5-476E-8C5D-B339F7D1A339 Q35020962-9325A632-404A-4294-84E6-5A25EAD77497 Q35208122-8284BE68-5C4D-45F7-B569-715A32E04565 Q35574024-1E697CB2-692A-4EBC-9667-08403F64E00A Q35628555-9EFC673E-396D-40BE-A1B0-B28241E8B517 Q35691522-20D35B3A-F8C3-4AC1-924F-024A056C6143 Q35768736-3EB17E57-370B-40D1-9AF8-2A2B34604CD7 Q35985743-4460CA17-1B96-409E-9D5E-EC996F83EB96 Q36001255-756A0695-8377-48D3-BEA8-064E12159DDF Q36055532-400D2DE0-228B-4BD8-90CE-FBBAC2D54189 Q36153802-10F46D75-0306-4DCD-B474-425CD9390347 Q36310888-7DABF243-8DA9-4D14-8099-341B9B0A3B36 Q36310912-87DAD311-88F4-47D6-A238-434D0ECC1C53 Q36565735-3B1422F5-E5AF-4E2F-BF7D-C563BEBFF8F5 Q36627295-C2F7BC90-2A0D-4A15-91DA-A312B7C4567A Q36694644-8F782EC6-3A93-471C-8104-E33A9129C41F Q36933740-AB086300-DB2A-4506-9963-FF36326CAEFC Q37195742-251BEAF9-32BA-4011-86EA-0E3B2E4784B9 Q37319379-8A73A367-35C0-4EA2-BB3E-34E03AFB4065 Q37333503-05D9D389-0706-4ACE-947C-D3E764B7C596 Q37444663-07F154F9-DDFE-4EEC-A8B4-036863461131 Q37533151-034A8E34-D113-4ADA-9649-91A24E96082D Q37656082-B7DC1DEA-2940-4F9E-BE85-39C90680E61A Q37696218-C66B3EE4-9743-4A3D-82B3-9A419195C838 Q37833828-00BC947E-1BE8-4043-BB29-3E264BBDA86C Q38022266-DF71ACA5-2F1E-40BA-ADF9-31DB8879E2F0 Q38106921-1D5824A2-B4A6-498C-8723-BB8266AC4797 Q38974307-09B54F11-48C0-42E5-9765-E70E4DCAD588 Q39372905-FEA39849-6A27-42EE-827C-AD5D94B18595

P2860

Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin.

http://www.wikidata.org/entity/Q35328384

description

2000 nî lūn-bûn

@nan

2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Nitric oxide prevents cardiova ...... overexpressing erythropoietin.

@ast

Nitric oxide prevents cardiova ...... overexpressing erythropoietin.

@en

type

label

Nitric oxide prevents cardiova ...... overexpressing erythropoietin.

@ast

Nitric oxide prevents cardiova ...... overexpressing erythropoietin.

@en

prefLabel

Nitric oxide prevents cardiova ...... overexpressing erythropoietin.

@ast

Nitric oxide prevents cardiova ...... overexpressing erythropoietin.

@en

P1433

Q35328384-DD0DA729-8643-4743-BED8-72988599E44D

P1476

Q35328384-B0290953-738E-4E2B-8313-3CD79B2109F0

P2093

Q35328384-039C7BCB-8C07-43F4-A6F4-857209B08362

Q35328384-080197AD-27FE-4318-AABD-0718B4F46D6C

Q35328384-18F18FCE-D31C-4E9A-BA08-FCADE8724A56

Q35328384-20A1AB53-5A59-4EE3-BF2F-2A66A4673AF5

Q35328384-3EE80DD2-17F0-4809-B009-260F93A26696

Q35328384-42C74646-8571-4211-B208-2542000BA217

Q35328384-460E3BEE-33BF-4D6A-AD2B-DA9B73F81A6B

Q35328384-66169944-BE91-4437-9BDA-80469AE13773

Q35328384-736A72F3-604B-4F9F-91C9-0D240CB6EF78

Q35328384-76501307-51AC-4CD2-8F20-F95A4BDAF39C

P2860

Q35328384-0B700C98-0699-45D3-9A26-6F0F0959C8DB

Q35328384-12A22788-E0F5-4A54-B765-B59103369DBC

Q35328384-141E8B0B-A352-45F7-8B46-D512A03123E6

Q35328384-2058430A-30CB-4470-A4DD-724E11A84EDF

Q35328384-29CC2686-D4A8-4CDA-B5D6-A54371ECD642

Q35328384-2B03A6E5-FFEE-4D10-83D0-7B76BD71C94E

Q35328384-33B43601-5506-4B07-ACB1-2EFF53BB58A4

Q35328384-3520DF7E-7C06-46BB-A73A-DDDE74EFAA20

Q35328384-3CA12BDE-0C30-4124-80CE-32E3C7579E2D

Q35328384-472900F7-2C21-4452-95F1-944F38B260D7

P304

Q35328384-05E981E5-5303-4A49-A5EE-D7C6C9496DE7

P31

Q35328384-392C7633-9216-460D-B63D-069D839A3A35

P356

Q35328384-932A0177-42A5-4CD7-8C91-8C2DAD1AC606

P407

Q35328384-FD438616-298A-4260-96EA-6FE0CBC9AF4C

P433

Q35328384-F63DF107-A785-4275-B4CE-D4FD26AA2E75

P478

Q35328384-E9891EC7-5213-454A-B348-D080E7E6C1C2

P577

Q35328384-0BFAEF9F-3FEF-4E02-AB2F-23E52CDA25C5

P5875

Q35328384-FE705511-EA4B-40DD-B3B9-139980DE94A7

P698

Q35328384-B1D6D194-B74D-4371-903C-770B1351D890

P921

Q35328384-A665178A-DFB9-4C7B-90AB-9CE71B0C5AA7

Q35328384-C2500171-747E-4191-B896-0CA06FD2A3CF

Q35328384-EA744156-A934-421C-8E2D-D7E3F7025AE3

P932

Q35328384-570C0B8E-8451-45C0-B2BD-9766E1FC1D3B

P356

PNAS.97.21.11609

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Nitric oxide prevents cardiova ...... overexpressing erythropoietin.

@en

P2093

B Rodenwaldt

http://www.w3.org/2001/XMLSchema#string

C Bauer

http://www.w3.org/2001/XMLSchema#string

C de Wit

http://www.w3.org/2001/XMLSchema#string

F T Ruschitzka

http://www.w3.org/2001/XMLSchema#string

G Noll

http://www.w3.org/2001/XMLSchema#string

H Lutz

http://www.w3.org/2001/XMLSchema#string

K Wagner

http://www.w3.org/2001/XMLSchema#string

M Gassmann

http://www.w3.org/2001/XMLSchema#string

M Kelm

http://www.w3.org/2001/XMLSchema#string

R H Wenger

http://www.w3.org/2001/XMLSchema#string

P2860

Vascular endothelial cells synthesize nitric oxide from L-arginine

Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

Localization of specific erythropoietin binding sites in defined areas of the mouse brain.

Erythropoietin receptor mRNA expression in human endothelial cells.

The oxyhemoglobin reaction of nitric oxide.

In vivo evidence that erythropoietin protects neurons from ischemic damage.

Nitric oxide synthases: which, where, how, and why?

Hematologic disorders and ischemic stroke. A selective review.

P304

11609-11613

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.97.21.11609

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2000-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235617407

http://www.w3.org/2001/XMLSchema#string

P698

11027359

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

17248

http://www.w3.org/2001/XMLSchema#string